News & Updates

Show Multimedia Only

Original New Drug Application Approvals by US FDA (16-31 May 2023)

01 Jun 2023

New drug applications approved by US FDA as of 16-31 May 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

01 Jun 2023

First-line TB treatment: Faropenem rivals ethambutol in efficacy, with fewer side effects

31 May 2023 by

Faropenem, when used in combination with the other standard treatment drugs for the first-line treatment of tuberculosis (TB) infection, appears to be noninferior to ethambutol, with faropenem having the added benefit of lower frequency of adverse events (AEs), according to the results of an open-label study in China.

31 May 2023

Children attending childcare more prone to respiratory virus infections

31 May 2023

Children who attend childcare are at greater risk of adenovirus and human metapneumovirus infection, and they are also often exposed to other respiratory viruses in such environments, reveals a study.

31 May 2023

Maternal influenza vaccination reduces ILI risk in infants

27 May 2023 by

Administration of maternal influenza vaccine during the first- or second-trimester of pregnancy reduces the risk of influenza-like illness (ILI) in the offspring, according to a study presented at ESPID 2023.

27 May 2023

Paediatric TB care riddled with uncertainty, study says

25 May 2023 by

Uncertainty weighs heavily on managing tuberculosis (TB) infection in children, with multi-level factors influencing the decision-making regarding testing and treatment.

25 May 2023

Nonsmoking, asbestos-exposed people still at risk of lung cancer

25 May 2023

Individuals who are exposed to asbestos are at higher risk of lung cancer despite modest exposure to tobacco, reveals a recent study.

25 May 2023

SLPI deficiency in cystic fibrosis much worse in P aeruginosa-infected female patients

25 May 2023

The presence of Pseudomonas aeruginosa worsens an already deficient airway secretory leukocyte protease inhibitor (SLPI), an antiprotease that helps prevent tissue damage, in patients with cystic fibrosis (CF), reports a study. Moreover, female patients show markedly lower SLPI levels than males.

25 May 2023

Dynamic hyperinflation decreases after EBVs treatment

24 May 2023

Endobronchial valves (EBVs) treatment results in a decrease in dynamic hyperinflation (DH), as shown in a study, which notes the association of such improvement with static changes.

24 May 2023